SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the ...

Health News // 1 day ago Study: Real-world results of GLP-1 drugs don't match trials Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive ... when it comes to treatment for sleep apnea in those with obesity, a new study reports.

Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main ... obstructive sleep apnoea, or cardiovascular disease, but without diabetes.

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide ... obstructive sleep apnoea, or cardiovascular disease, but who did not have diabetes.

Smoky air often has obvious short-term health effects like coughing and sore throat, but it can also have long-term impacts ...

Communities across Asia's Himalayan Hindu Kush region face heightened disaster risks this monsoon season with temperatures ...

Consumer prices were only slightly affected by President Donald Trump’s tariffs in May, according to new numbers from the U.S. Bureau of Labor Statistics.

Sleep apnea and weight ... Zepbound is a prescription injection used for weight loss ... There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss ...